Shares of Phizer (NYSE:PFE) are pulling back nicely to the trendline going back to March of last year. The share is also touching its 200MA. Results are due on Tuesday next week so Im keeping a close eye on this one. If we get a bounce the share could be on its way back to previous highs reached in November 2018, given a potential return of 20% over the coming year. As a bonus, the share is also a good dividend payer. Pfizers contribution to the vaccine and Covid fight should also provide some long term support.